Researchers have developed a new method to analyze CT scans to help predict how patients with non-small cell lung cancer (NSCLC) might respond to treatments. This method, called CT-RadScore, uses 12 specific features from CT images to look at the biological characteristics of a tumor.
The study looked at several groups of patients from different medical centers. The results showed that this scoring system could help predict overall survival. Specifically, a higher score was linked to worse survival outcomes. The system also showed promise in predicting how patients might respond to immunotherapy, chemotherapy, and targeted therapies.
While these findings are promising, it is important to remember that this was an observational study showing associations, not direct proof of cause. The researchers noted that more work is needed. Specifically, larger studies and standardized methods are required before this tool can be used in everyday clinical practice.
Patients should view this as an early sign of potential progress in personalized medicine. This tool could eventually help doctors choose the most effective treatment for each individual, but it is not yet ready for use in hospitals.